GlaxoSmithKline Pharmaceuticals Ltd
NSE:GLAXO

Watchlist Manager
GlaxoSmithKline Pharmaceuticals Ltd Logo
GlaxoSmithKline Pharmaceuticals Ltd
NSE:GLAXO
Watchlist
Price: 2 320 INR -2.53% Market Closed
Market Cap: ₹393B

Profitability Summary

GlaxoSmithKline Pharmaceuticals Ltd's profitability score is 79/100. We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

79/100
Profitability
Score

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

79/100
Profitability
Score
79/100
Profitability
Score

Margins

Earnings Waterfall
GlaxoSmithKline Pharmaceuticals Ltd

Margins Comparison
GlaxoSmithKline Pharmaceuticals Ltd Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
IN
GlaxoSmithKline Pharmaceuticals Ltd
NSE:GLAXO
393.9B INR
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
1T USD
Loading...
Loading...
Loading...
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
525.7B USD
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
276.7B CHF
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
211.5B GBP
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.8T DKK
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
221.8B CHF
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
271.6B USD
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
146B USD
Loading...
Loading...
Loading...

Return on Capital

Return on Capital Comparison
GlaxoSmithKline Pharmaceuticals Ltd Competitors

Country Company Market Cap ROE ROA ROCE ROIC
IN
GlaxoSmithKline Pharmaceuticals Ltd
NSE:GLAXO
393.9B INR
Loading...
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
1T USD
Loading...
Loading...
Loading...
Loading...
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
Loading...
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
525.7B USD
Loading...
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
276.7B CHF
Loading...
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
211.5B GBP
Loading...
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.8T DKK
Loading...
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
221.8B CHF
Loading...
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
271.6B USD
Loading...
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
146B USD
Loading...
Loading...
Loading...
Loading...

Free Cash Flow

Free Cash Flow Analysis
GlaxoSmithKline Pharmaceuticals Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate